Hereditary Cancer in Clinical Practice


Open Access Highly Access Email this article to a friend

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

Dewkoemar Ramsoekh*, Anja Wagner, Monique E van Leerdam, Dennis Dooijes, Carli MJ Tops, Ewout W Steyerberg and Ernst J Kuipers

Hereditary Cancer in Clinical Practice 2009, 7:17 doi:10.1186/1897-4287-7-17

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.